Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications
- PMID: 28637807
- PMCID: PMC5507445
- DOI: 10.1161/CIRCIMAGING.116.005461
Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications
Abstract
Sudden cardiac death (SCD) is a devastating event afflicting 350 000 Americans annually despite the availability of life-saving preventive therapy, the implantable cardioverter defibrillator. SCD prevention strategies are hampered by over-reliance on global left ventricular ejection fraction <35% as the most important criterion to determine implantable cardioverter defibrillator candidacy. Annually in the United States alone, this results in ≈130 000 implantable cardioverter defibrillator placements at a cost of >$3 billion but only a 5% incidence per year of appropriate firings. This approach further fails to identify individuals who experience the majority, as many as 80%, of SCD events, which occur in the setting of more preserved left ventricular ejection fraction. Better risk stratification is needed to improve care and should be guided by direct pathophysiologic markers of arrhythmic substrate, such as specific left ventricular structural abnormalities. There is an increasing body of literature to support the prognostic value of cardiac magnetic resonance imaging with late gadolinium enhancement in phenotyping the left ventricular to identify those at highest risk for SCD. Cardiac magnetic resonance has unparalleled tissue characterization ability and provides exquisite detail about myocardial structure and composition, abnormalities of which form the direct, pathophysiologic substrate for SCD. Here, we review the evolution and the current state of cardiac magnetic resonance for imaging the arrhythmic substrate, both as a research tool and for clinical applications.
Keywords: arrhythmias, cardiac; cardiomyopathies; death, sudden, cardiac; fibrosis; magnetic resonance imaging; tachycardia, ventricular; ventricular dysfunction, left.
© 2017 American Heart Association, Inc.
Figures








Similar articles
-
Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.Circ Arrhythm Electrophysiol. 2017 Jan;10(1):e004067. doi: 10.1161/CIRCEP.116.004067. Circ Arrhythm Electrophysiol. 2017. PMID: 28087564
-
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.Circ Cardiovasc Imaging. 2012 Mar;5(2):178-86. doi: 10.1161/CIRCIMAGING.111.968024. Epub 2012 Jan 20. Circ Cardiovasc Imaging. 2012. PMID: 22267750 Free PMC article.
-
Role of CMR imaging in risk stratification for sudden cardiac death.JACC Cardiovasc Imaging. 2013 Mar;6(3):392-406. doi: 10.1016/j.jcmg.2012.11.011. JACC Cardiovasc Imaging. 2013. PMID: 23473115 Review.
-
Myocardial fibrosis predicts ventricular tachyarrhythmias.Trends Cardiovasc Med. 2017 Jul;27(5):363-372. doi: 10.1016/j.tcm.2017.01.011. Epub 2017 Feb 2. Trends Cardiovasc Med. 2017. PMID: 28262437 Review.
-
Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action.Europace. 2018 Sep 1;20(FI2):f148-f152. doi: 10.1093/europace/eux305. Europace. 2018. PMID: 29236981 Review.
Cited by
-
Substrate Spatial Complexity Analysis for the Prediction of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e007975. doi: 10.1161/CIRCEP.119.007975. Epub 2020 Mar 18. Circ Arrhythm Electrophysiol. 2020. PMID: 32188287 Free PMC article.
-
A CURE for What Ails in Cardiac Resynchronization Therapy: Defibrillator or Pacemaker Only?JACC Cardiovasc Imaging. 2020 Apr;13(4):937-939. doi: 10.1016/j.jcmg.2019.11.013. Epub 2019 Dec 18. JACC Cardiovasc Imaging. 2020. PMID: 31864988 Free PMC article. No abstract available.
-
Left ventricular fibrosis in arrhythmic mitral valve prolapse: quantification and comparison of semi-automated techniques assessed by cardiac magnetic resonance.Int J Cardiovasc Imaging. 2024 Feb;40(2):275-285. doi: 10.1007/s10554-023-03006-6. Epub 2023 Dec 23. Int J Cardiovasc Imaging. 2024. PMID: 38141098 Free PMC article.
-
Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients.BMC Cardiovasc Disord. 2019 Oct 21;19(1):230. doi: 10.1186/s12872-019-1218-9. BMC Cardiovasc Disord. 2019. PMID: 31638918 Free PMC article.
-
Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators.J Cardiovasc Magn Reson. 2021 Oct 21;23(1):115. doi: 10.1186/s12968-021-00806-4. J Cardiovasc Magn Reson. 2021. PMID: 34670574 Free PMC article.
References
-
- Fishman GI, Chugh SS, DiMarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen P-S, Estes M, Jouven X, Kwong R, Lathrop DA, Mascette AM, Nerbonne JM, O’Rourke B, Page RL, Roden DM, Rosenbaum DS, Sotoodehnia N, Trayanova NA, Zheng Z-J. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335–2348. - PMC - PubMed
-
- Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, Kapa S, Kremers MS, Lindsay BD, Stevenson LW. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2013;61:1318–1368. - PubMed
-
- Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kaab S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014;35:1642–1651. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical